<DOC>
	<DOCNO>NCT01300923</DOCNO>
	<brief_summary>Fragile X syndrome ( FXS ) common inherited form developmental disability . FXS inherit carrier parent , often mother . FXS associate severe interfere behavioral symptom include anxiety relate symptom , attention deficit hyperactivity , aggressive behavior . Approximately 25-33 % individual FXS also meet criterion autistic disorder . The hypothesis study treatment acamprosate reduce inattention/hyperactivity , language impairment , irritability , social deficit , cognitive delay youth FXS . The purpose study investigate effectiveness tolerability acamprosate youth Fragile X Syndrome assess potential psychophysiological difference FXS autism spectrum disorder .</brief_summary>
	<brief_title>Acamprosate Youth With Fragile X Syndrome</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Autism Spectrum Disorder</mesh_term>
	<mesh_term>Fragile X Syndrome</mesh_term>
	<mesh_term>Acamprosate</mesh_term>
	<criteria>Male female outpatient age 5 17 year . Confirmed diagnosis Fragile X Syndrome base upon genetic testing . Stable dose psychotropic medication least 2 week prior baseline . Subjects stable seizure disorder history childhood febrile seizure include . Clinical Global ImpressionSeverity Score 4 ( Moderately Ill ) great . Must good physical health . Subjects child bearing age gender require utilize birth control applicable . Diagnosis schizophrenia , another psychotic disorder , bipolar disorder alcohol substance abuse base Diagnostic Statistical Manual Fourth EditionText Revised ( DSMIVTR ) . A significant medical condition heart , liver , renal pulmonary disease unstable seizure disorder . Females positive urine pregnancy test Creatinine clearance less 30 . Concomitant use another glutamatergic agent ( memantine , riluzole , dcycloserine , amantadine topiramate , gabapentin , among others . Evidence hypersensitivity acamprosate potentially serious adverse effect . Subjects , opinion investigator , unsuitable way participate study include unable comply requirement study reason .</criteria>
	<gender>All</gender>
	<minimum_age>5 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>May 2015</verification_date>
	<keyword>Fragile X Syndrome</keyword>
	<keyword>Acamprosate</keyword>
</DOC>